Concomitant mitral valve surgery in patients with moderate ischemic mitral regurgitation undergoing coronary artery

Byung Jin Kim1, Yun Seok Kim2, Ho Jin Kim3

  • 1Medical Sciences Division, University of Oxford, Oxford, UK.

Insights

Adding mitral valve surgery to coronary artery bypass grafting for moderate ischemic mitral regurgitation increases early risks. Long-term benefits are not significant, suggesting CABG alone may be preferable for these patients.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Mitral Valve Disease

Background:

  • The clinical benefit of concurrent mitral valve (MV) surgery with coronary artery bypass grafting (CABG) for moderate ischemic mitral regurgitation (iMR) is debated.
  • Understanding the risks and benefits is crucial for patient management.

Purpose of the Study:

  • To evaluate the impact of concomitant MV surgery on outcomes in patients with moderate iMR undergoing CABG.
  • To compare early and long-term clinical and echocardiographic results between CABG-only and CABG with MV surgery.

Main Methods:

  • A cohort of 710 patients with moderate iMR undergoing CABG (1990-2015) was analyzed.
  • 116 patients (16.3%) had concomitant MV surgery (MVS), while 594 (83.7%) had CABG only.
  • Propensity score matching was used to adjust for baseline differences and compare outcomes.

Main Results:

  • Concomitant MV surgery was associated with increased early mortality, low cardiac output syndrome, and surgical bleeding.
  • After adjustment, the risk of early death remained significantly higher in the MVS group.
  • Long-term survival showed a trend towards increased mortality with MVS, but this difference diminished at 1 year post-surgery.
  • Both groups showed similar improvements in left ventricular ejection fraction and reverse remodeling.

Conclusions:

  • Concomitant MV surgery in moderate iMR patients undergoing CABG increases early mortality and complication risks.
  • No significant long-term clinical or echocardiographic benefits were observed with the addition of MV surgery.
  • CABG alone may be a safer option for selected patients with moderate iMR.
Abstract

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
596
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
554
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
358
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
357
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
625
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
505